chr5-132642195-C-G
Variant summary
The NM_005732.4(RAD50):c.3770C>G (p.Ser1257*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. This is a loss-of-function variant that does not trigger NMD. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (BayesDel (noAF)) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_005732.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Nijmegen breakage syndrome-like disorderInheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, PanelApp Australia
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Pathogenic. The variant received 10 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PVS1Null variant in LOF gene | Non-NMD frameshift: ≥4 downstream pathogenic — very strong evidence preserved (PVS1); Stop-gained (exon 25 of 25) at amino acid 1257 of 1312; NMD not predicted. 11 pathogenic variants downstream support preserved loss-of-function impact. | ||
| PM2Absent/extremely low in population databases | Absent from gnomAD (AD/XL gene) — PM2; Absent from gnomAD at well-covered site (MOI: AD+AR) (base 0.0001, raised to 0.000198 by highest known P/LP ClinVar AF 0.000198) — PM2 moderate. |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_005732.4. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
RAD50 | MANE Select | c.3770C>G p.Ser1257* | stop_gained | Exon 25 of 25 | Prot: NP_005723.2 | |
TH2LCRR | n.189+3G>C | splice_regionintron | Intron 2 of 2 | Prot: | ||
TH2LCRR | n.175-3930G>C | intron | Intron 1 of 1 | Prot: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
RAD50 | TSL:1MANE Select | c.3770C>G p.Ser1257* | stop_gained | Exon 25 of 25 | Prot: ENSP00000368100.4 UniProt: | |
ENSG00000283782 | TSL:5 | c.3473C>G p.Ser1158* | stop_gained | Exon 27 of 27 | Prot: ENSP00000492349.2 UniProt: | |
TH2LCRR | TSL:1 | n.189+3G>C | splice_regionintron | Intron 2 of 2 | Prot: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 5 sources | |||||
GnomAD3 genomes | Cov:32 | ||||
GnomAD4 exome | Cov:31 | ||||
GnomAD4 genome | Cov:32 | ||||
TOPMed (Bravo) | AF: 0.00000756 | ||||
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.00 | AC:0 | Hom:0 | AN:34852 | |
ClinVar
Not reported inComputational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 40 | |
BayesDel_addAF | Pathogenic | 0.62 | D |
BayesDel_noAF | Pathogenic | 0.65 | |
CADD | Pathogenic | 42 | |
DANN | Uncertain | 1.0 | |
Eigen | Pathogenic | 1.1 | |
Eigen_PC | Pathogenic | 0.96 | |
FATHMM_MKL | Pathogenic | 0.98 | D |
GPN-Star LLR | N/A | -10 | |
GPN-Star score | N/A | 10 | |
Mutation Taster | N/A | 7/193 | disease causing |
PhyloP100 | Uncertain | 5.8 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.050 | |
SpliceAI score (max) | Benign | 0.020 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.